ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세팔로스포린 의약품 시장 규모는 향후 몇 년 동안 안정적인 성장세를 보일 것으로 예상되며, 2029년에는 4.4%의 연평균 성장률로 206억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 노인 인구의 증가, 세균 감염에 대한 인식 증가, 입원 환자 증가, 새로운 세팔로스포린 제제의 지속적인 개발에 기인합니다. 이 기간 동안 예상되는 주요 동향으로는 제형 기술 혁신, 첨단 제조 기술의 통합, 새로운 세팔로스포린 유도체의 부상, 약물전달 시스템의 발전 등이 있습니다.
감염성 질환의 증가는 향후 몇 년 동안 세팔로스포린 의약품 시장의 성장을 견인할 것으로 예상됩니다. 감염성 질환은 세균, 바이러스, 진균, 곰팡이, 기생충 등 미생물에 의해 발생하는 질병으로 사람에서 사람으로 전염될 수 있습니다. 이러한 감염증의 증가는 주로 항균제 내성 문제가 확대되고 있기 때문이며, 이전에는 대처가 가능했던 감염증이 치료가 어려워지고 그 결과 더 지속적이고 광범위한 질병이 발생하게 됩니다. 세팔로스포린 의약품은 광범위한 항균 특성을 가지고 있어 다양한 세균 병원균에 효과적이며, 이러한 감염증의 치료에 도움이 되고 있습니다. 세팔로스포린 의약품은 신속하고 효과적인 치료로 치료 기간을 단축하고 환자의 회복을 촉진합니다. 예를 들어, 2023년 11월 미국 보건사회복지부는 2022년에 새로 기록된 만성 B형 간염 환자가 전년 대비 11% 증가했다고 보고했습니다. 그 결과, 감염성 질환의 이환율 증가는 세팔로스포린 의약품 시장의 성장에 기여하고 있습니다.
세팔로스포린 의약품 시장의 주요 기업들은 항균제 내성과 싸우고 전 세계적으로 증가하는 약제 내성 감염에 대응하기 위해 그람음성균 감염을 표적으로 하는 치료제와 같은 첨단 치료 옵션을 창출하는 데 주력하고 있습니다. 그람음성균 감염을 치료하기 위해서는 기존 항생제에 대한 내성을 본질적으로 증가시키는 독특한 세포벽 구조를 가진 박테리아를 표적으로 하는 특수 항생제를 사용해야 합니다. 예를 들어, 2024년 5월 Shionogi & Co. Ltd.는 그람음성균 감염증의 치료제로 특수 항생제를 사용한다고 발표했습니다. 일본 제약회사 시오노기(Shionogi & Co. Ltd.)는 2024년 5월, 약제 내성 균주를 포함한 중증 그람음성균 감염에 대응하기 위해 개발된 새로운 항생제 페트로자(세피데로쿨)를 발표했습니다. 혁신적인 트로이 목마 전략을 통해 여러 내성 메커니즘을 우회할 수 있어 대체 약물이 제한적인 환자에게 중요한 치료 옵션을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 세팔로스포린 의약품 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 세팔로스포린 의약품 시장 : 성장률 분석
세계의 세팔로스포린 의약품 시장 실적 : 규모와 성장, 2019-2024년
세계의 세팔로스포린 의약품 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 세팔로스포린 의약품 전체 시장(TAM)
제6장 시장 세분화
세계의 세팔로스포린 의약품 시장 : 세대별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제1세대
제2세대
제3세대
제4세대
제5세대
세계의 세팔로스포린 의약품 시장 : 투여 경로별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
경구
비경구
국소
세계의 세팔로스포린 의약품 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
피부 감염증
호흡기 감염증
요로감염
성감염증
귀감염증
기타
세계의 세팔로스포린 의약품 시장 : 유통 채널별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
병원 약국
소매 약국
온라인 약국
세계의 세팔로스포린 의약품 시장 : 제1세대 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
Cefazolin
Cephradine
Cephalexin
세계의 세팔로스포린 의약품 시장 : 제2세대 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
Cefuroxime
Loracarbef
Cefaclor
Cefprozil
세계의 세팔로스포린 의약품 시장 : 제3세대 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
Ceftriaxone
Cefdinir
Cefotaxime
Ceftazidime
세계의 세팔로스포린 의약품 시장 : 제4세대 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
Cefepime
Cefpirome
세계의 세팔로스포린 의약품 시장 : 제5세대 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
Ceftaroline
Ceftobiprole
제7장 지역별·국가별 분석
세계의 세팔로스포린 의약품 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 세팔로스포린 의약품 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
세팔로스포린 의약품 시장 : 경쟁 구도
세팔로스포린 의약품 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Abbott Laboratories
Novartis AG
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd.
Astellas Pharma Inc.
Baxter International
Macleods Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd.
Lupin Limited
Zydus Lifesciences Limited
Alkem Laboratories Ltd.
Mankind Pharma Limited
Aristo Pharmaceuticals Ltd
Hetero Drugs Ltd
Covalent Laboratories Private Limited
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
세팔로스포린 의약품 시장 2029년 : 새로운 기회를 제공하는 국가
세팔로스포린 의약품 시장 2029년 : 새로운 기회를 제공하는 부문
세팔로스포린 의약품 시장 2029년 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Cephalosporin drugs belong to the beta (B)-lactam class of antibiotics and are used to combat bacterial infections by disrupting the synthesis of the bacterial cell wall, resulting in cell death. These broad-spectrum antibiotics are categorized into generations based on their range of antimicrobial activity. Cephalosporins are frequently prescribed for various infections, including those of the respiratory tract, skin, urinary tract, and central nervous system, such as meningitis.
The cephalosporin drug generations include the first, second, third, fourth, and fifth generations. First-generation cephalosporins are mainly effective against gram-positive bacteria like streptococcus and staphylococcus species, with limited efficacy against gram-negative organisms. They can be administered orally, via injection, or topically. Their clinical uses encompass the treatment of skin, respiratory, urinary tract, sexually transmitted, and ear infections, among others. These medications are available through hospital pharmacies, retail drugstores, and online platforms.
The cephalosporin drugs market research report is one of a series of new reports from The Business Research Company that provides cephalosporin drugs market statistics, including the cephalosporin drugs industry's global market size, regional shares, competitors with the cephalosporin drugs market share, detailed cephalosporin drugs market segments, market trends and opportunities, and any further data you may need to thrive in the cephalosporin drugs market. This cephalosporin drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cephalosporin drugs market size has grown steadily in recent years. It will grow from $16.56 billion in 2024 to $17.34 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. Growth during the historical period can be credited to the rising prevalence of bacterial infections, the escalation of antibiotic resistance, increased healthcare spending, and the growing demand for generic medications.
The cephalosporin drugs market size is expected to see steady growth in the next few years. It will grow to $20.64 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. Growth projected for the forecast period can be attributed to the expanding elderly population, heightened awareness of bacterial infections, a rise in hospital admissions, and continued development of new cephalosporin formulations. Key trends anticipated during this period include innovations in drug formulation technologies, integration of advanced technology in manufacturing, the emergence of novel cephalosporin derivatives, and progress in drug delivery systems.
The increasing occurrence of infectious diseases is projected to drive the expansion of the cephalosporin drugs market in the coming years. Infectious diseases are illnesses triggered by microorganisms such as bacteria, viruses, fungi, or parasites, which can be transmitted from one person to another. This rise in infectious diseases is primarily attributed to the growing issue of antimicrobial resistance, which renders previously manageable infections more difficult to treat, resulting in more persistent and widespread illness. Cephalosporin drugs are instrumental in treating these infections due to their broad-spectrum antibacterial properties, making them effective against a wide range of bacterial pathogens. They help shorten treatment duration by delivering rapid and effective relief, thereby enhancing patient recovery. For example, in November 2023, the U.S. Department of Health and Human Services reported that newly documented chronic hepatitis B cases increased by 11% in 2022 compared to the previous year. Consequently, the rising incidence of infectious diseases is contributing to the growth of the cephalosporin drugs market.
Leading players in the cephalosporin drugs market are concentrating on creating advanced treatment options, such as those targeting gram-negative bacterial infections, to combat antimicrobial resistance and address the increasing global burden of drug-resistant infections. Treating gram-negative bacterial infections involves using specialized antibiotics to target bacteria that possess a distinct cell wall structure, which makes them inherently more resistant to conventional antibiotics. For instance, in May 2024, Shionogi & Co. Ltd., a pharmaceutical firm based in Japan, introduced FETROJA (Cefiderocol), a new antibiotic developed to combat severe gram-negative bacterial infections, including drug-resistant strains. Its innovative Trojan horse strategy enables it to bypass multiple resistance mechanisms, offering a vital therapeutic option for patients with limited alternatives.
In January 2024, Venatorx Pharmaceuticals Inc., a pharmaceutical company based in the U.S., formed a partnership with Menarini Group to secure exclusive rights for the commercialization of cefepime-taniborbactam across 96 countries. This collaboration is intended to enhance global availability of this next-generation antibiotic, designed to target multidrug-resistant bacterial infections. Menarini Group, headquartered in Italy, manufactures and develops cephalosporin-based drugs.
Major players in the cephalosporin drugs market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., AstraZeneca plc, Abbott Laboratories, Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Baxter International, Macleods Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Mankind Pharma Limited, Aristo Pharmaceuticals Ltd, Hetero Drugs Ltd, Covalent Laboratories Private Limited.
North America was the largest region in the cephalosporin drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cephalosporin drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cephalosporin drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cephalosporin drugs market consists of sales of keflex, rocephin, and maxipime. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cephalosporin Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cephalosporin drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cephalosporin drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cephalosporin drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Generation: First Generation; Second Generation; Third Generation; Fourth Generation; Fifth Generation
2) By Route of Administration: Oral; Parenteral; Topical
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cephalosporin Drugs Market Characteristics
3. Cephalosporin Drugs Market Trends And Strategies
4. Cephalosporin Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Cephalosporin Drugs Growth Analysis And Strategic Analysis Framework
5.1. Global Cephalosporin Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cephalosporin Drugs Market Growth Rate Analysis
5.4. Global Cephalosporin Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cephalosporin Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cephalosporin Drugs Total Addressable Market (TAM)
6. Cephalosporin Drugs Market Segmentation
6.1. Global Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First Generation
Second Generation
Third Generation
Fourth Generation
Fifth Generation
6.2. Global Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Topical
6.3. Global Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Skin Infection
Respiratory Tract Infection
Urinary Tract Infection
Sexually Transmitted Infection
Ear Infection
Other Applications
6.4. Global Cephalosporin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.5. Global Cephalosporin Drugs Market, Sub-Segmentation Of First Generation, By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cefazolin
Cephradine
Cephalexin
6.6. Global Cephalosporin Drugs Market, Sub-Segmentation Of Second Generation, By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cefuroxime
Loracarbef
Cefaclor
Cefprozil
6.7. Global Cephalosporin Drugs Market, Sub-Segmentation Of Third Generation, By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ceftriaxone
Cefdinir
Cefotaxime
Ceftazidime
6.8. Global Cephalosporin Drugs Market, Sub-Segmentation Of Fourth Generation, By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cefepime
Cefpirome
6.9. Global Cephalosporin Drugs Market, Sub-Segmentation Of Fifth Generation, By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ceftaroline
Ceftobiprole
7. Cephalosporin Drugs Market Regional And Country Analysis
7.1. Global Cephalosporin Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cephalosporin Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cephalosporin Drugs Market
9.1. China Cephalosporin Drugs Market Overview
9.2. China Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cephalosporin Drugs Market
10.1. India Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cephalosporin Drugs Market
11.1. Japan Cephalosporin Drugs Market Overview
11.2. Japan Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cephalosporin Drugs Market
12.1. Australia Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cephalosporin Drugs Market
13.1. Indonesia Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cephalosporin Drugs Market
14.1. South Korea Cephalosporin Drugs Market Overview
14.2. South Korea Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cephalosporin Drugs Market
15.1. Western Europe Cephalosporin Drugs Market Overview
15.2. Western Europe Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cephalosporin Drugs Market
16.1. UK Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cephalosporin Drugs Market
17.1. Germany Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cephalosporin Drugs Market
18.1. France Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cephalosporin Drugs Market
19.1. Italy Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cephalosporin Drugs Market
20.1. Spain Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cephalosporin Drugs Market
21.1. Eastern Europe Cephalosporin Drugs Market Overview
21.2. Eastern Europe Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cephalosporin Drugs Market
22.1. Russia Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cephalosporin Drugs Market
23.1. North America Cephalosporin Drugs Market Overview
23.2. North America Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cephalosporin Drugs Market
24.1. USA Cephalosporin Drugs Market Overview
24.2. USA Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cephalosporin Drugs Market
25.1. Canada Cephalosporin Drugs Market Overview
25.2. Canada Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cephalosporin Drugs Market
26.1. South America Cephalosporin Drugs Market Overview
26.2. South America Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cephalosporin Drugs Market
27.1. Brazil Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cephalosporin Drugs Market
28.1. Middle East Cephalosporin Drugs Market Overview
28.2. Middle East Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cephalosporin Drugs Market
29.1. Africa Cephalosporin Drugs Market Overview
29.2. Africa Cephalosporin Drugs Market, Segmentation By Generation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cephalosporin Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cephalosporin Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cephalosporin Drugs Market Competitive Landscape And Company Profiles
